Owner of Turkish Drug Wholesaler Pleads Guilty to Smuggling Fake Cancer Drugs

Sabahaddin Akman, owner and manager of Turkish drug wholesaler Ozay Pharmaceuticals pleaded guilty to counterfeit drug charges in Federal Court. Ozay Pharmaceuticals was one of the foreign-based drug exporters responsible introducing counterfeit cancer medications into the secure U. S. drug supply. Turkish citizen Sabahaddin Akman pleaded guilty to charges of smuggling misbranded and adulterated cancer…

[...]

Regeneca Worldwide, A Division Of Vivaceuticals, Inc Voluntarily Recalls RegeneSlim Appetite Control Capsules Due To The Presence Of DMAA That May Pose Possible Health Risk

This is a reprint of an FDA Alert. Recall — Firm Press Release FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. Contact Consumer/Media: 949-281-2600 FOR IMMEDIATE…

[...]

Dégardin, Klara, Yves Roggo, and Pierre Margot. “Understanding and fighting the medicine counterfeit market.” Journal Of Pharmaceutical & Biomedical Analysis 87, (January 18, 2014): 167-175.

Abstract Medicine counterfeiting is a serious worldwide issue, involving networks of manufacture and distribution that are an integral part of industrialized organized crime. Despite the potentially devastating health repercussions involved, legal sanctions are often inappropriate or simply not applied. The difficulty in agreeing on a definition of counterfeiting, the huge profits made by the counterfeiters…

[...]

da Justa Neves, Diana Brito, Ravane Gracy Ament Marcheti, and Eloisa Dutra Caldas. “Incidence of anabolic steroid counterfeiting in Brazil.” Forensic Science International 228, no. 1-3 (May 10, 2013): e81-e83.

AbstractThis retrospective study reports data obtained from the National Institute of Criminalistics of the Brazilian Federal Police Department (DPF) on 3676 anabolic products seized between 2006 and 2011. Anabolic androgenic steroids (AAS) were declared on the labels of 96.2% of the products. About one third of the products declared to be from Paraguay, and 14.3%…

[...]

“Operation Pangea VI: combating sale of unapproved medicines.” WHO Drug Information 27, no. 3 (September 2013): 227.

Abstract: The article reports on a 2013 decision which the U.S. Food and Drug Administration and several other international law enforcement and regulatory agencies made to take legal and regulatory action against more than 9,600 web sites from various countries that illegally market unproven prescription drugs to consumers. "Operation Pangea VI: combating sale of unapproved…

[...]